Evolution of disparities in pediatric epilepsy surgery use over two decades
Alex S Aguirre1, Ellen C Broekhuizen2, Daan A Pijs3
1Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Pediatrics, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
Insights
Despite increased use of epilepsy surgery for children with drug-resistant epilepsy, disparities in access based on insurance, race, and ethnicity have widened between 2004 and 2024.
Area of Science:
- Pediatric Neurology
- Health Services Research
- Surgical Outcomes
Background:
- Drug-resistant epilepsy affects a significant number of children.
- Epilepsy surgery is a crucial treatment option for refractory cases.
- Understanding trends in surgical access is vital for equitable care.
Purpose of the Study:
- To analyze the evolution of epilepsy surgery utilization in pediatric patients with drug-resistant epilepsy from 2004 to 2024.
- To identify and quantify disparities in surgical access based on insurance, race, and ethnicity over two decades.
Main Methods:
- Retrospective analysis of the Pediatric Health Information System database (2004-2024).
- Examined epilepsy surgery rates and time to surgery.
- Multivariable analyses assessed predictors including insurance type, race, and ethnicity.
Main Results:
- Epilepsy surgery rates increased significantly, from 4.0 to 15.8 per 100 person-years between 2004-2006 and 2022-2024.
- Disparities widened: Odds ratios for private insurance (1.50 to 1.75), White vs. Black patients (1.35 to 2.39), and non-Hispanic vs. Hispanic patients (1.08 to 1.23) all increased.
- Hazard ratios showed similar widening trends for these disparities.
Conclusions:
- Epilepsy surgery use has increased in pediatric patients with drug-resistant epilepsy.
- Significant disparities persist and are widening across insurance types, race, and ethnicity.
- Addressing these inequities is critical for improving surgical access for all children with epilepsy.
Objective:
To describe how disparities in the use of epilepsy surgery have evolved between 2004 and 2024 among children with drug-resistant epilepsy.
Methods:
Retrospective descriptive study using the Pediatric Health Information System database. Outcomes were use of epilepsy surgery and time from first diagnosis of drug-resistant epilepsy to epilepsy surgery, main predictors were type of insurance, race, and ethnicity.
Results:
We studied 50,953 patients with drug-resistant epilepsy (median (p25-p75) age: 8.0 (3.5-13.4) years, 54% males), of whom 7220 (14.2%) patients had at least one epilepsy surgery. The number of epilepsy surgeries per 100 person-years increased from 4.0 in 2004-2006 to 15.8 in 2022-2024. On multivariable analysis, the odds ratio (OR) of receiving epilepsy surgery for patients with private versus public insurance increased from OR: 1.50 (1.25-1.80) in 2004-2006 to OR: 1.75 (1.50-2.04) in 2022-2024; increased for White patients versus Black patients from OR: 1.35 (1.03-1.76) in 2004-2006 to OR: 2.39 (1.86-3.08) in 2022-2024; and increased for Not Hispanic/Latino patients versus Hispanic/Latino patients from OR: 1.08 (0.85-1.38) in 2007-2009 (first years with the "Not Hispanic/Latino" category) to OR: 1.23 (1.01-1.51) in 2022-2024. On multivariable Cox regression analysis, the hazard ratio (HR) of receiving epilepsy surgery for patients with private insurance versus public insurance increased from HR: 1.55 (1.32-1.82) in 2004-2006 to HR: 1.92 (1.65-2.24) in 2022-2024; increased for White patients versus Black patients from HR: 1.46 (1.14-1.86) in 2004-2006 to HR: 2.67 (2.05-3.48) in 2022-2024; and increased for Not Hispanic/Latino patients versus Hispanic/Latino patients from HR: 1.20 (0.96-1.51) in 2007-2009 to HR: 1.30 (1.06-1.60) in 2022-2024.
Conclusion:
Despite increasing use of epilepsy surgery in pediatric patients with drug-resistant epilepsy between 2004 and 2024, disparities by type of insurance, race, and ethnicity are widening.
Related Concept Videos
The Evidence for Evolution
Convergent Evolution
Eukaryotic Evolution
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
Synteny and Evolution
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Gene Evolution - Fast or Slow?


